Redirecting to https://www.taihooncology.com/us/newsroom/press-releases/Taiho-Oncology-Inc-Announces-FDA-Approval-of-LONSURF-for-Refractory-Metastatic-Colorectal-Cancer...

Click here if your browser doesn't automatically take you to this page.